meta_pixel
Tapesearch Logo
Log in
Kennedy Saves the World

Therapy In Limbo: The FDA's MDMA Decision & What Went Wrong

Kennedy Saves the World

FOX News Podcasts

Entertainment News, Society & Culture, News Commentary, News

3.2639 Ratings

🗓️ 19 June 2024

⏱️ 24 minutes

🧾️ Download transcript

Summary

Key advisers to the U.S. Food and Drug Administration (FDA) advised against approval for MDMA therapy for PTSD patients last week, questioning the drug’s sponsor, Lykos Therapeutics, on their results. The CEO of Lykos Therapeutics Amy Emerson shares her frustration with the disapproval and details what went wrong with the evaluation of the FDA advisory committee. Follow Kennedy on Twitter: @KennedyNation Kennedy Now Available on YouTube: https://bit.ly/4311mhD. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

Exclusively on Disney Plus.

0:02.0

It's hard and it's brutal and that's what makes it special.

0:06.0

The multi-award winning series, FX's The Bear, is back for a brand new season.

0:11.0

Upon my signal, unleash hell.

0:15.0

And every second counts.

0:17.0

When that shows zero, this restaurant ceases operations.

0:21.8

FX is the bear.

0:23.1

New season now streaming exclusively on Disney Plus.

0:27.1

18 plus subscription required season C's apply. Welcome to this episode of Kennedy saves the world.

0:47.8

This is a follow-up on a chat that we had a few weeks ago where I talked about the FDA and their committee that gave the thumbs down to MDMA therapy, assisted therapy, to treat post-traumatic stress disorder.

1:07.6

You know, there have been just phenomenal statistics, as I have spoken about.

1:11.9

Many people who suffer from PTSD had achieved cure status with MDMA guided therapy.

1:21.4

And everyone who was optimistic about the state of this kind of treatment and research really felt like it was going to do very well going through the FDA approval process.

1:38.3

This is an advisory committee of that through a number of arbitrary reasons has decided to advise against FDA approval for this

1:51.9

treatment. And one of the reasons they said was because the company that was sponsoring and

1:59.7

carrying out the therapy, the clinical trials, was the very company

2:05.7

that would provide the MDMA. It's called Lycos therapeutics, and the company was, if I'm not mistaken,

2:16.6

created to shepherd this process along responsibly

2:21.1

and well integrated.

2:23.9

So when the FDA finally gave approval for this type of MDMA therapy guided treatment,

2:31.4

there would be a quarterback there ready to shepherd the process

2:38.5

forward through the marketplace to consumers and people suffering from PTSD and other ailments

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from FOX News Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of FOX News Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.